Inflammation and degeneration in multiple sclerosis - PubMed (original) (raw)
Review
. 2003 Dec:24 Suppl 5:S265-7.
doi: 10.1007/s10072-003-0170-7.
Affiliations
- PMID: 14652785
- DOI: 10.1007/s10072-003-0170-7
Review
Inflammation and degeneration in multiple sclerosis
W Brück et al. Neurol Sci. 2003 Dec.
Abstract
Multiple (MS) sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with the pathological hallmarks of inflammation, demyelination, axon loss and gliosis. In the initial relapsing-remitting phase of the disease, the inflammatory-demyelinating component seems to predominate, whereas the progressive disease appears to be characterized by a neurodegenerative component leading to extensive neuroaxonal damage in the MS brain. Axon loss most likely determines the persistent neurological deficit in progressive MS. Recent studies pointed out that axon damage occurs early in the disease and during lesion development. Two different phases of axon degeneration were characterized, the first occurring during active myelin breakdown and the second in chronic demyelinated plaques in which the naked axon seems more susceptible to further damage. The exact mechanisms and effector molecules of axonal degeneration, however, are not yet defined, and an axon-protective therapy has not yet been established.
Similar articles
- Protecting axons in multiple sclerosis.
Wilkins A, Scolding N. Wilkins A, et al. Mult Scler. 2008 Sep;14(8):1013-25. doi: 10.1177/1352458508091370. Epub 2008 Jul 16. Mult Scler. 2008. PMID: 18632772 Review. - From inflammation to degeneration: the lessons of clinical trials.
Comi G. Comi G. Neurol Sci. 2003 Dec;24 Suppl 5:S295-7. doi: 10.1007/s10072-003-0178-z. Neurol Sci. 2003. PMID: 14652793 Review. - [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS, Bader J, Kaiser CC, Schroeter M, Fink GR, Addicks K, Kuerten S. Recks MS, et al. Fortschr Neurol Psychiatr. 2011 Mar;79(3):161-70. doi: 10.1055/s-0029-1246014. Epub 2011 Mar 10. Fortschr Neurol Psychiatr. 2011. PMID: 21394707 Review. German. - Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
Andrews HE, Nichols PP, Bates D, Turnbull DM. Andrews HE, et al. Med Hypotheses. 2005;64(4):669-77. doi: 10.1016/j.mehy.2004.09.001. Med Hypotheses. 2005. PMID: 15694681 - Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
Onuki M, Ayers MM, Bernard CC, Orian JM. Onuki M, et al. Microsc Res Tech. 2001 Mar 15;52(6):731-9. doi: 10.1002/jemt.1057. Microsc Res Tech. 2001. PMID: 11276125
Cited by
- Amelioration of experimental autoimmune encephalomyelitis by gemfibrozil in mice via PPARβ/δ: implications for multiple sclerosis.
Mondal S, Sheinin M, Rangasamy SB, Pahan K. Mondal S, et al. Front Cell Neurosci. 2024 May 21;18:1375531. doi: 10.3389/fncel.2024.1375531. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38835441 Free PMC article. - Three-dimensional virtual histology of the cerebral cortex based on phase-contrast X-ray tomography.
Eckermann M, van der Meer F, Cloetens P, Ruhwedel T, Möbius W, Stadelmann C, Salditt T. Eckermann M, et al. Biomed Opt Express. 2021 Nov 15;12(12):7582-7598. doi: 10.1364/BOE.434885. eCollection 2021 Dec 1. Biomed Opt Express. 2021. PMID: 35003854 Free PMC article. - Lactate Threshold Training Program on Patients with Multiple Sclerosis: A Multidisciplinary Approach.
Amato A, Ragonese P, Ingoglia S, Schiera G, Schirò G, Di Liegro CM, Salemi G, Di Liegro I, Proia P. Amato A, et al. Nutrients. 2021 Nov 27;13(12):4284. doi: 10.3390/nu13124284. Nutrients. 2021. PMID: 34959834 Free PMC article. Clinical Trial. - Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.
Matejuk A, Vandenbark AA, Offner H. Matejuk A, et al. Front Neurol. 2021 May 31;12:672455. doi: 10.3389/fneur.2021.672455. eCollection 2021. Front Neurol. 2021. PMID: 34135852 Free PMC article. Review. - Engine Failure in Axo-Myelinic Signaling: A Potential Key Player in the Pathogenesis of Multiple Sclerosis.
Bergaglio T, Luchicchi A, Schenk GJ. Bergaglio T, et al. Front Cell Neurosci. 2021 Feb 10;15:610295. doi: 10.3389/fncel.2021.610295. eCollection 2021. Front Cell Neurosci. 2021. PMID: 33642995 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical